NEFL and synucleinopathy: The NfL levels in the blood and CSF were increased in disorders characterized by proteopathic brain lesions, including tauopathy, β-amyloidosis, and α-synucleinopathy as shown in animal studies (Bacioglu et al., 2016[6]).